RIVM_Logo

Current status and use of short/medium-term models for assessment of carcinogenicity of human pharmaceuticals: regulatory perspectives

 

Home / Documenten en publicaties / Current status and use of short/medium-term models for assessment of carcinogenicity of human pharmaceuticals: regulatory perspectives

RIVM De zorg voor morgen begint vandaag
Menu